← Open Payments lookup

OLAYEMI OLAJUYIGBE: Open Payments

NPI 1073170205 · ELKRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 33 payments from 9 companies in 2025. Trend: 2023 $710 · 2024 $632 · 2025 $781

Food & beverage: $781
CompanyPaymentsAmount
Alkermes, Inc.9$165
TMS NeuroHealth Centers Inc.2$149
Lundbeck LLC8$149
ABBVIE INC.4$85
Neurocrine BioSciences, Inc.3$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
Otsuka America Pharmaceutical, Inc.2$46
E.R. Squibb & Sons, L.L.C.2$45
Teva Pharmaceuticals USA, Inc.1$14

Products named: ARISTADA, TMS NeuroHealth Centers Inc., VRAYLAR, REXULTI, INGREZZA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, CAPLYTA.

Industry payments across MD — which companies pay providers there.